14 December 2023
On Wednesday 13 December, MEPs gathered in the European Parliament plenary session in Strasbourg adopted the Sub-Committee of Public Health Report on non-communicable diseases (NCDs) with 578 votes in favour, 39 against and 15 abstentions. The Report calls for better prevention and early diagnosis of non-communicable diseases (NCDs) and closer cooperation between national health authorities needed and now represents the consensus position of the full Parliament.
Non-communicable diseases (NCDs) such as cancer are responsible for 80% of the disease burden (the largest share of EU member states’ healthcare expenditures with an estimated cost of EUR 115 billion or 0.8% of GDP annually), and cause 90% of all deaths in the EU countries.
The new Report by the Parliament considers the Europe’s Beating Cancer Plan as a building block for the EU's future ambitions in addressing the NCD challenge. In particular, MEPs made strong recommendations in the fields of:
The European Cancer Organisation closely followed the legislative file and advised MEPs in particular to ensure that the following points were included in the adopted text:
Commenting on the new report, Riccardo Moschetti, ECO Policy Officer said:
“It is promising to see the levels of support that exist right across the European Parliament for accelerated action on meeting the NCD challenge. Now there is work ahead to convert the Parliament’s recommendations into clear action, including tighter tobacco and alcohol control measures, and greater attention to matters such as hereditary cancer risk and health literacy about early warning signs of cancer. The recent publication of the Time to Accelerate: Together Against Cancer manifesto sets out in more precise form the kind of actions the EU can support member states with in these areas.”
You can read our recommendations for a better and healthier Europe and endorse our Time To Accelerate Manifesto here: https://www.europeancancer.org/manifesto
For further information about this topic, and to connect to ECO's work on the subject, please contact Riccardo Moschetti at riccardo.moschetti@europeancancer.org